Letter to the editor regarding "A prospective, controlled study of the botanical compound mixture LCS101 for chemotherapy-induced hematological complications in breast cancer" by Yaal-Hahoshen et al. (The Oncologist 2011;16:1197-1202).

K.D. Mooiman; A.K.L. Goey; I. Meijerman; J.H. Beijnen; J.H.M. Schellens

Letter to the editor regarding "A prospective, controlled study of the botanical compound mixture LCS101 for chemotherapy-induced hematological complications in breast cancer" by Yaal-Hahoshen et al. (The Oncologist 2011;16:1197-1202).

K.D. Mooiman, A.K.L. Goey, I. Meijerman, J.H. Beijnen, J.H.M. Schellens

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	740-1; author reply 742-3
Number of pages	2
Journal	Oncologist
Volume	17
Issue number	5
Publication status	Published - 2012

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

Mooiman, K. D., Goey, A. K. L., Meijerman, I., Beijnen, J. H., & Schellens, J. H. M. (2012). Letter to the editor regarding "A prospective, controlled study of the botanical compound mixture LCS101 for chemotherapy-induced hematological complications in breast cancer" by Yaal-Hahoshen et al. (The Oncologist 2011;16:1197-1202). Oncologist, 17(5), 740-1; author reply 742-3.

@article{bb3db94c6d5a4ae8be9b113f9187aa18,

title = "Letter to the editor regarding {"}A prospective, controlled study of the botanical compound mixture LCS101 for chemotherapy-induced hematological complications in breast cancer{"} by Yaal-Hahoshen et al. (The Oncologist 2011;16:1197-1202).",

author = "K.D. Mooiman and A.K.L. Goey and I. Meijerman and J.H. Beijnen and J.H.M. Schellens",

year = "2012",

language = "Undefined/Unknown",

volume = "17",

pages = "740--1; author reply 742--3",

journal = "Oncologist",

issn = "1083-7159",

publisher = "Oxford University Press",

number = "5",

}

Mooiman, KD, Goey, AKL, Meijerman, I, Beijnen, JH & Schellens, JHM 2012, 'Letter to the editor regarding "A prospective, controlled study of the botanical compound mixture LCS101 for chemotherapy-induced hematological complications in breast cancer" by Yaal-Hahoshen et al. (The Oncologist 2011;16:1197-1202).', Oncologist, vol. 17, no. 5, pp. 740-1; author reply 742-3.

Letter to the editor regarding "A prospective, controlled study of the botanical compound mixture LCS101 for chemotherapy-induced hematological complications in breast cancer" by Yaal-Hahoshen et al. (The Oncologist 2011;16:1197-1202). / Mooiman, K.D.; Goey, A.K.L.; Meijerman, I. et al.
In: Oncologist, Vol. 17, No. 5, 2012, p. 740-1; author reply 742-3.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Letter to the editor regarding "A prospective, controlled study of the botanical compound mixture LCS101 for chemotherapy-induced hematological complications in breast cancer" by Yaal-Hahoshen et al. (The Oncologist 2011;16:1197-1202).

AU - Mooiman, K.D.

AU - Goey, A.K.L.

AU - Meijerman, I.

AU - Beijnen, J.H.

AU - Schellens, J.H.M.

PY - 2012

Y1 - 2012

M3 - Article

SN - 1083-7159

VL - 17

SP - 740-1; author reply 742-3

JO - Oncologist

JF - Oncologist

IS - 5

ER -